Latest other liabilities for MBII: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Marrone Bio Innovations (MBII) currently reports a other liabilities of $0 as of March 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Marrone Bio Innovations's other liabilities history and peer comparisons.
Marrone Bio Innovations's other liabilities changed from $0 to $0 (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Marrone Bio Innovations reported $0 in other liabilities as of March 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Marrone Bio Innovations, and consider following MBII for alerts when major investors trade the stock.
Marrone Bio Innovations is classified in the Materials sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MBII with unrelated industries.